{
    "clinical_study": {
        "@rank": "154841", 
        "acronym": "COPES", 
        "arm_group": {
            "arm_group_label": "Ceradan Regimen", 
            "description": "Ceradan Cream and Ceradan Wash"
        }, 
        "brief_summary": {
            "textblock": "This is a prospective, open label, single  arm, and observational and multicenter study to\n      assess the correlation between PEST and SCORAD scores in the management of AD with the\n      Ceradan\u00ae regimen."
        }, 
        "brief_title": "Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan\u00ae Regimen", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Atopic Dermatitis", 
        "condition_browse": {
            "mesh_term": [
                "Dermatitis", 
                "Dermatitis, Atopic"
            ]
        }, 
        "detailed_description": {
            "textblock": "All eligible patients shall apply permitted topical steroid(s) according to standard local\n      practice\n\n      For the entire study period, patients should apply Ceradan Cream\u00ae liberally twice daily or\n      more, if required and use a non-soap based wash once or twice daily.\n\n      At the screening visit, patients will receive a diary card and will be asked to track their\n      atopic dermatitis symptoms for 12 weeks.\n\n      Retrospective information on other topical treatments used will be collected at baseline."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male and female children aged \u22656 months to \u22646 years\n\n          -  Baseline PEST score of 3- 4\n\n          -  Diagnosis of mild to moderate atopic dermatitis, with grading of 3 to11, as per the\n             NESS\n\n          -  Diagnosis of current flare (increased dryness, itching, redness, swelling and general\n             irritability) at baseline visit according to Investigator's judgement\n\n          -  Patients who have not visited the dermatologist before (dermatologist-na\u00efve)\n\n          -  Agree to participate and provide written consent by parent or guardian (and assent if\n             applicable)\n\n        Exclusion Criteria:\n\n          -  History of severe episodes of atopic dermatitis (for example: oozing, crusts)\n\n          -  Clinical signs of skin infection (viral, bacterial or fungal)\n\n          -  Grading of >11 as defined by the Nottingham Eczema Severity Score (NESS) within 3\n             months prior to study inclusion\n\n          -  Known reaction or allergy to test drug or excipients or steroids\n\n          -  History of cutaneous or systemic viral (including HIV or AIDS), cutaneous mycotic or\n             cutaneous bacterial disease requiring a topical or systemic therapy during the study\n             period\n\n          -  Patients who are receiving any investigational drug or who have taken part in a\n             clinical study with an investigational drug within three months prior to the start of\n             study treatment\n\n          -  The patient has been exposed to below therapy within the set timeframe:\n\n             i. Systemic administration of corticosteroid - four weeks; ii. Systemic\n             administration of immunosuppressive drugs - four weeks; iii. UV therapy  four weeks\n\n          -  Any serious medical condition which, in the opinion of the investigator, may\n             interfere with the evaluation of the results\n\n          -  Parents/guardians may be unable to complete the patient diaries or questionnaires"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "6 Years", 
            "minimum_age": "6 Months", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Children Aged Six Months to Six Years with Atopic Dermatitis"
            }
        }, 
        "enrollment": {
            "#text": "58", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02073591", 
            "org_study_id": "HYP2013/001"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ceradan Regimen", 
                "intervention_name": "Ceradan Cream", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Ceradan Regimen", 
                "intervention_name": "Ceradan Wash", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Children", 
            "Atopic Dermatitis", 
            "Ceradan", 
            "PEST", 
            "SCORAD"
        ], 
        "lastchanged_date": "April 16, 2014", 
        "link": {
            "description": "Ceradan Cream", 
            "url": "http://ceradan311.com/ceradan1.php"
        }, 
        "location": [
            {
                "contact": {
                    "email": "veronlu@nsc.gov.sg", 
                    "last_name": "Veron Lu", 
                    "phone": "+65 6350 8582"
                }, 
                "facility": {
                    "address": {
                        "city": "Singapore", 
                        "country": "Singapore"
                    }, 
                    "name": "National Skin Centre"
                }, 
                "investigator": {
                    "last_name": "Yoke Chin Giam, Prof", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Ren.Mee.Hiong@kkh.com.sg", 
                    "last_name": "Michelle MH Ren", 
                    "phone": "+65 6394 8241"
                }, 
                "facility": {
                    "address": {
                        "city": "Singapore", 
                        "country": "Singapore"
                    }, 
                    "name": "KK Women's and Children's Hospital"
                }, 
                "investigator": {
                    "last_name": "Mark, Jean Ann Koh, Dr", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Singapore"
        }, 
        "number_of_groups": "1", 
        "official_title": "A Phase IV, Open Label, Single Arm, Multicenter, Observational Study to Evaluate the Correlation Between PEST and SCORAD Score in the Management of Atopic Dermatitis With Use of Ceradan\u00ae Regimen in Children Aged Six Months to Six Years", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Singapore: Health Sciences Authority", 
                "Singapore: Institutional Review Board"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Correlation will be assessed by Pearson correlation at baseline, Week 4 and Week 12 between both scores. Karl Pearson correlation coefficient (\u03c1) will be provided. Percent Change from Baseline will be calculated for Week 4 and Week 12 and correlation will also be calculated for it.", 
            "measure": "Correlation between the mean Patient Eczema Severity Time (PEST) score and mean Scoring Atopic Dermatitis (SCORAD) Index at Week 4 and Week 12, as compared to baseline", 
            "safety_issue": "No", 
            "time_frame": "12 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02073591"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Efficacy by change in SCORAD score at Week 4 and Week 12 as compared to baseline", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }, 
            {
                "measure": "Efficacy by change in AUC PEST score at Week 4, Week 12 as compared to baseline and three months prior to baseline", 
                "safety_issue": "No", 
                "time_frame": "12 weeks"
            }
        ], 
        "source": "Hyphens Pharma Pte Ltd", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hyphens Pharma Pte Ltd", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}